These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10687844)

  • 1. ACOG committee opinion. First-trimester screening for fetal anomalies with nuchal translucency. Number 223, October 1999. Committee on Genetics. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 2000 Jan; 68(1):71-2. PubMed ID: 10687844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pregnancy outcome in 1,252 fetuses after nuchal translucency measurement in the 1st trimester].
    Horner E; Holzgreve W; Batucan C; Tercanli S
    Praxis (Bern 1994); 2002 Feb; 91(7):261-5. PubMed ID: 11883361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal translucency.
    Blakemore KJ
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):388-90. PubMed ID: 9674083
    [No Abstract]   [Full Text] [Related]  

  • 4. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACOG committee opinion. Advanced paternal age: risks to the fetus. Number 189, October 1997. Committee on Genetics. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 1997 Dec; 59(3):271-2. PubMed ID: 9486524
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.
    Yagel S; Imbar T; Valsky DV
    Ultrasound Obstet Gynecol; 2002 Apr; 19(4):417-21. PubMed ID: 11952979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sonographic first trimester screening in Switzerland].
    Lapaire O; Sartorius G; Holzgreve W; Tercanli S
    Praxis (Bern 1994); 2005 Feb; 94(6):199-204. PubMed ID: 15754531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonography in the detection of fetal anomalies in early pregnancy.
    Economides DL; Whitlow BJ; Braithwaite JM
    Br J Obstet Gynaecol; 1999 Jun; 106(6):516-23. PubMed ID: 10426606
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuchal translucency as an important ultrasound screening tool for the early diagnosis of first trimester chromosomal abnormalities. A preliminary experience.
    Borrelli AL; Borrelli P; Felicetti M; Di Domenico A; Laboccetta A; Torella M
    Minerva Ginecol; 2004 Apr; 56(2):179-80. PubMed ID: 15258549
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuchal translucency thickness and outcome in chromosome translocation diagnosed in the first trimester.
    Sepulveda W; Be C; Youlton R; Carstens E; Reyes M
    Prenat Diagn; 2001 Sep; 21(9):726-8. PubMed ID: 11559907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nuchal translucency and fetal chromosomal defects.
    Mol BW; Pajkrt E; Bilardo CM
    N Engl J Med; 1998 Apr; 338(17):1229; author reply 1229-30. PubMed ID: 9556395
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of three-dimensional ultrasound to nuchal translucency measurement in early pregnancy (10-14 weeks): a preliminary study.
    Chung BL; Kim HJ; Lee KH
    Ultrasound Obstet Gynecol; 2000 Feb; 15(2):122-5. PubMed ID: 10775994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregnancy outcome in fetuses with increased nuchal translucency thickness at 10-14 weeks of pregnancy].
    Maymon R; Dreazen E; Tovbin Y; Weinraub Z; Herman A
    Harefuah; 1999 Jun; 136(11):851-5, 916, 915. PubMed ID: 10955127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.